MetaCap

Nutex Health (NUTX) vs Radware (RDWR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Radware (RDWR) has outperformed Nutex Health (NUTX) over the past year, gaining 45.7% versus a gain of 18.8%. Radware is the larger company by market cap ($1.36 billion vs $1.12 billion), about 1.2 times the size, while Nutex Health is growing revenue faster (+82.4% vs +9.8%). On valuation, Nutex Health trades at a lower forward P/E (8.0x vs 22.8x for Radware).

Nutex Health converts more of its revenue into profit, with a net margin of 8.1% versus 6.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NUTX+18.78%RDWR+45.73%
+73%+16%-42%
Nov 21, 20251 yearNov 20, 2026
NUTX-87.97%RDWR+4.95%
+18%-43%-105%
Apr 4, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NUTX versus RDWR key metrics
MetricNUTXRDWR
Share price$162.64$32.22
Market cap$1.12B$1.36B
1-day change+0.33%-4.51%
YTD return-1.20%+33.75%
1-year return+18.78%+45.73%
5-year return—+9.67%
P/E ratio (TTM)7.0468.55
Forward P/E8.0022.80
EPS (TTM)$23.11$0.47
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$875.26M$301.85M
Revenue growth (YoY)+82.36%+9.81%
Net income (latest FY)$70.79M$20.26M
Gross margin50.76%80.67%
Operating margin31.49%3.78%
Net margin8.09%6.71%
52-week high$226.16$38.50
52-week low$83.99$21.92
Distance from 52-week high-28.09%-16.31%
Analyst consensusstrong_buynone
Avg. price target upside+92.86%+28.80%
Average volume149.94K392.25K
Shares outstanding6.86M42.08M
Employees1,0931,228
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RDWR has outperformed NUTX by 26.9 percentage points over the past year.
  • Radware trades at a higher earnings multiple (68.6x vs 7.0x trailing P/E).
  • Nutex Health grew revenue faster in its latest fiscal year (+82.36% vs +9.81%).

About Nutex Health

NUTX stock →

Nutex Health Inc. operates as a healthcare services and operations company in the United States.

Consumer Discretionary · Business Services · 1,093 employees

About Radware

RDWR stock →

Radware Ltd., together with its subsidiaries, develops, manufactures, and markets cyber security and application delivery solutions for cloud, on-premises, and software defined data centers. The company operates in two segments, Radware's Core Business and The Hawks' Business.

Consumer Discretionary · Business Services · 1,228 employees

NUTX vs RDWR FAQ

Which is bigger, Nutex Health or Radware?

Radware (RDWR) is larger, with a market capitalization of $1.36B compared with $1.12B for Nutex Health (NUTX).

Which stock has performed better over the past year, NUTX or RDWR?

RDWR returned +45.73% over the past 12 months, compared with +18.78% for NUTX (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, NUTX or RDWR?

NUTX has the lower trailing P/E at 7.0, versus 68.6 for RDWR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Nutex Health and Radware in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons